INVO Bioscience Inc

Company Profile

INVO Bioscience Inc had its IPO on 2012-05-21 under the ticker symbol INVO.

The company operates in the Healthcare sector and Medical Devices industry. INVO Bioscience Inc has a staff strength of 15 employees.

Stock update

Shares of INVO Bioscience Inc opened at $1.4 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.16 - $1.41, and closed at $1.24.

This is a -6.18% slip from the previous day's closing price.

A total volume of 52,334 shares were traded at the close of the day’s session.

In the last one week, shares of INVO Bioscience Inc have slipped by -17.44%.

INVO Bioscience Inc's Key Ratios

INVO Bioscience Inc has a market cap of $3.70 million, indicating a price to book ratio of 5.6708 and a price to sales ratio of 1.4563.

In the last 12-months INVO Bioscience Inc’s revenue was $1.18 million with a gross profit of $535273 and an EBITDA of $-9537655. The EBITDA ratio measures INVO Bioscience Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, INVO Bioscience Inc’s operating margin was -816.73% while its return on assets stood at -92.01% with a return of equity of -1224.53%.

In Q2, INVO Bioscience Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 116.2%.

INVO Bioscience Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0.0595

PEG

Its diluted EPS in the last 12-months stands at $25.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into INVO Bioscience Inc’s profitability.

INVO Bioscience Inc stock is trading at a EV to sales ratio of 2.4976 and a EV to EBITDA ratio of -1.1923. Its price to sales ratio in the trailing 12-months stood at 1.4563.

INVO Bioscience Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$6.64 million

Total Liabilities

$4.47 million

Operating Cash Flow

$0

Capital Expenditure

$261505

Dividend Payout Ratio

0%

INVO Bioscience Inc ended 2024 with $6.64 million in total assets and $0 in total liabilities. Its intangible assets were valued at $6.64 million while shareholder equity stood at $-1705494.00.

INVO Bioscience Inc ended 2024 with $0 in deferred long-term liabilities, $4.47 million in other current liabilities, 83.00 in common stock, $-54574923.00 in retained earnings and $0 in goodwill. Its cash balance stood at $112485.00 and cash and short-term investments were $112485.00. The company’s total short-term debt was $1,260,914 while long-term debt stood at $0.

INVO Bioscience Inc’s total current assets stands at $842125.00 while long-term investments were $1.13 million and short-term investments were $0. Its net receivables were $74908.00 compared to accounts payable of $770000.00 and inventory worth $280018.00.

In 2024, INVO Bioscience Inc's operating cash flow was $0 while its capital expenditure stood at $261505.

Comparatively, INVO Bioscience Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.24

52-Week High

$33

52-Week Low

$1.16

Analyst Target Price

$20

INVO Bioscience Inc stock is currently trading at $1.24 per share. It touched a 52-week high of $33 and a 52-week low of $33. Analysts tracking the stock have a 12-month average target price of $20.

Its 50-day moving average was $2.52 and 200-day moving average was $7.97 The short ratio stood at 0.23 indicating a short percent outstanding of 0%.

Around 477.3% of the company’s stock are held by insiders while 1468% are held by institutions.